System and method of haemodialysis
AssigneeCaptere Pty Ltd
InventorPaul Moroz
Life of this patent
Estimating the term…
Loading patent…
AssigneeCaptere Pty Ltd
InventorPaul Moroz
Estimating the term…
The present disclosure provides a method of removing a target substance from blood of a patient, the method comprising steps of: providing a complexing agent, especially a supra-molecular compound or core particle, adapted for selectively binding a target molecule or target entity in the blood of the patient in a complex, e.g. a supra-molecular complex; administering the complexing agent into the patient's blood, preferably into an extracorporeal blood flow pathway, for binding with the target molecule or the target entity; conveying the blood having the complexing agent through a treatment zone of an extracorporeal blood flow pathway for a predetermined period of time to bind or incorporate the target molecule or target entity within the blood in a complex, such as a supra-molecular complex; and removing the complex (e.g. supra-molecular complex) from the blood by haemodialysis, which preferably includes one or more of filtration, ultrafiltration, convection, or adsorption. The disclosure thus also provides a system (1) for removing a target substance from blood of a patient, the system (1) comprising: an extracorporeal blood flow pathway (2) for connection to a patient and for guiding or conveying a flow of blood from the patient along the pathway; a treatment zone (5) arranged in the extracorporeal blood flow pathway (2) for mixing a complexing agent (C) with the blood adapted to bind a target molecule (M) in a complex (X), especially a supra-molecular complex or core particle complex, as the blood flows through the treatment zone (5); and a haemodialysis unit (4) for separating the complex (X) from the blood via one or more of filtration, ultra-filtration, convection, and membrane adsorption, with or without magnetic assistance.
A method of removing a target molecule from blood of a patient, the target molecule being a mid-sized molecule having a mass in the range of about 500 Da to 50 kDa, the method comprising steps of:
A system for removing a target molecule from blood of a patient, wherein the target molecule is a mid-sized molecule having a mass in the range of about 500 Da to 50 kDa, the system comprising:
A method of removing a target molecule from blood of a patient, wherein the target molecule is a mid-sized molecule having a mass in the range of about 500 Da to 50 kDa, the method comprising steps of:
Dependencies are inferred from the claim text.